Researchers with the American Gastroenterological Association (AGA) release a comprehensive set of guidelines on the use of biomarkers for monitoring and managing Crohn disease in patients.
The American College of Physicians have released an updated set of guidelines addressing when and how clinicians should screen for colorectal cancer in patients.
After clinical trials to assess the safety, efficacy, and maintenance use, the FDA has approved the first oral treatment for moderately to severely active Crohn disease.
The American Gastroenterological Association (AGA) released a set of guidelines that outlines the use of biomarkers to treat and monitor ulcerative colitis in patients.
The American College of Gastroenterology (ACG) provides new updates for clinicians and patients with recommendations for the diagnosis and management of celiac disease.
Researchers examined the impact that time-to-initiation of biologic treatment had on the risk of adverse outcomes among individuals with Crohn disease.
The authors of a first-of-its-kind systematic review examined if using probiotics concomitantly with antibiotics regimens could impact antibiotic-induced changes to the gut microbiome.
